Improving health and well-being for Black cancer survivors through community support
Scaling Social Determinants of Health Screening, Social Support, and Anti-Racism Training to Reduce Inequities in Minority Cancer Survivor Health and Well-Being in Washington, D.C.
This study is trying to see if connecting Black breast and prostate cancer survivors with community resources and support can improve their health and well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1116 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medstar Health Research Institute Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Washington, District of Columbia) |
| Trial ID | NCT05301114 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the health and well-being of Black breast and prostate cancer survivors by implementing social risk factor screening and referral processes. It will map community resources in Washington, D.C., and assess the impact of Community Health Worker (CHW) support on survivors' quality of life and social connections. Additionally, the study will evaluate the effects of anti-racism training for healthcare staff on patient-reported discrimination. The overarching goal is to create sustainable clinical-community linkages to address social determinants of health and reduce health disparities.
Who should consider this trial
Good fit: Ideal candidates for this study are Black or African American individuals diagnosed with stage I-III breast or prostate cancer who have completed curative treatment or are approximately 6 months from diagnosis for stage IV cancer.
Not a fit: Patients who do not identify as Black or African American or those with cancer types other than breast or prostate may not receive benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life and health outcomes for Black cancer survivors by addressing social needs and reducing discrimination.
How similar studies have performed: Other studies have shown success in addressing social determinants of health and improving outcomes for cancer survivors, indicating that this approach has potential.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of stage I-III breast or prostate cancer and completed curative treatment (surgery, radiation, chemotherapy) or finalized treatment plan (e.g. watch and wait); OR Stage IV breast or prostate cancer approximately 6 months from diagnosis * Black or African American race
Where this trial is running
Washington, District of Columbia
- MedStar Washington Hospital Center — Washington, District of Columbia, United States (Recruiting)
Study contacts
- Principal investigator: Hannah Arem, PhD — Medstar Health Research Institute
- Study coordinator: Hannah Arem, PhD
- Email: hannah.arem@medstar.net
- Phone: 202-893-2430
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.